Sales rise 70.74% to Rs 4.61 crore
Net profit of Beryl Drugs reported to Rs 0.34 crore in the quarter ended June 2021 as against net loss of Rs 0.20 crore during the previous quarter ended June 2020. Sales rose 70.74% to Rs 4.61 crore in the quarter ended June 2021 as against Rs 2.70 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales4.612.70 71 OPM %15.4011.48 -PBDT0.600.17 253 PBT0.30-0.18 LP NP0.34-0.20 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
